XML 88 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Method Investments
3 Months Ended
Mar. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Investments and Noncontrolling Interests [Text Block] Investments and Noncontrolling Interests

The following table presents MPLX’s equity method investments at the dates indicated:
 
Ownership as of
 
Carrying value at
 
March 31,
 
March 31,
 
December 31,
(In millions, except ownership percentages)
2020
 
2020
 
2019
L&S
 
 
 
 
 
MarEn Bakken Company LLC
25%
 
$
479

 
$
481

Illinois Extension Pipeline Company, L.L.C.
35%
 
271

 
265

LOOP LLC
41%
 
239

 
238

Andeavor Logistics Rio Pipeline LLC(1)
67%
 
200

 
202

Minnesota Pipe Line Company, LLC
17%
 
190

 
190

Whistler Pipeline LLC(1)
38%
 
163

 
134

W2W Holdings LLC(1)(2)
50%
 
76

 

Wink to Webster Pipeline LLC(1)(2)
15%
 

 
126

Explorer Pipeline Company
25%
 
81

 
83

Other(1)
 
 
55

 
55

Total L&S
 
 
1,754

 
1,774

G&P
 
 
 
 
 
MarkWest Utica EMG, L.L.C.(1)
57%
 
712

 
1,984

Sherwood Midstream LLC(1)
50%
 
546

 
537

MarkWest EMG Jefferson Dry Gas Gathering Company, L.L.C.(1)
67%
 
302

 
302

Rendezvous Gas Services, L.L.C.(1)
78%
 
167

 
170

Sherwood Midstream Holdings LLC(1)
52%
 
155

 
157

Centrahoma Processing LLC
40%
 
150

 
153

Other(1)
 
 
206

 
198

Total G&P
 
 
2,238

 
3,501

Total
 
 
$
3,992

 
$
5,275


(1)
Investments deemed to be VIE’s. Some investments included within “Other” have also been deemed to be VIE’s.
(2)
During the three months ended March 31, 2020, we contributed our ownership in Wink to Webster Pipeline LLC to W2W Holdings LLC.

For those entities that have been deemed to be VIE’s, neither MPLX nor any of its subsidiaries have been deemed to be the primary beneficiary due to voting rights on significant matters. While we have the ability to exercise influence through participation in the management committees which make all significant decisions, since we have equal influence over each committee as a joint interest partner and all significant decisions require the consent of the other investors without regard to economic interest, we have determined that these entities should not be consolidated and apply the equity method of accounting with respect to our investments in each entity.

Sherwood Midstream has been deemed the primary beneficiary of Sherwood Midstream Holdings due to its controlling financial interest through its authority to manage the joint venture. As a result, Sherwood Midstream consolidates Sherwood Midstream Holdings. Therefore, MPLX also reports its portion of Sherwood Midstream Holdings’ net assets as a component of its investment in Sherwood Midstream. As of March 31, 2020, MPLX has a 24.1 percent indirect ownership interest in Sherwood Midstream Holdings through Sherwood Midstream.

MPLX’s maximum exposure to loss as a result of its involvement with equity method investments includes its equity investment, any additional capital contribution commitments and any operating expenses incurred by the subsidiary operator in excess of its compensation received for the performance of the operating services. MPLX did not provide any financial support to equity method investments that it was not contractually obligated to provide during the three months ended March 31, 2020.

During the first quarter of 2020, we assessed certain of our equity method investments for impairment as a result of a number of first quarter events and circumstances as discussed in Note 1. During the first quarter of 2020, we recorded an other than temporary impairment for three joint ventures in which we have an interest. Impairment of these investments was $1,264 million, of which $1,251 million was related to MarkWest Utica EMG, L.L.C. and its investment in Ohio Gathering Company, L.L.C. The fair value of the investments was determined based upon applying the discounted cash flow method, which is an income approach. The discounted cash flow fair value estimate is based on known or knowable information at the interim measurement date. The significant assumptions that were used to develop the estimate of the fair value under the discounted cash flow method include management’s best estimates of the expected future cash flows, including prices and volumes, the weighted average cost of capital and the long-term growth rate. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions and factors. As such, the fair value of these equity method investments represents a Level 3 measurement. As a result, there can be no assurance that the estimates and assumptions made for purposes of the impairment test will prove to be an accurate prediction of the future. The impairment was recorded through “Income from equity method investments.” The impairments were largely due to a reduction in forecasted volumes gathered and processed by the systems operated by the joint ventures.

Summarized financial information for MPLX’s equity method investments for the three months ended March 31, 2020 and 2019 is as follows:
 
Three Months Ended March 31, 2020
(In millions)
VIEs
 
Non-VIEs
 
Total
Revenues and other income
$
(217
)
 
$
337

 
$
120

Costs and expenses
104

 
132

 
236

Income from operations
(321
)
 
205

 
(116
)
Net income
(337
)
 
186

 
(151
)
(Loss)/income from equity method investments(1)
$
(1,222
)
 
$
38

 
$
(1,184
)
(1)
Includes the impact of any basis differential amortization or accretion in addition to the impairment of $1,264 million.
 
Three Months Ended March 31, 2019(1)
(In millions)
VIEs
 
Non-VIEs
 
Total
Revenues and other income
$
155

 
$
391

 
$
546

Costs and expenses
77

 
198

 
275

Income from operations
78

 
193

 
271

Net income
71

 
181

 
252

Income from equity method investments
$
27

 
$
50

 
$
77


(1)
Financial information for the first quarter of 2019 has been retrospectively adjusted for the acquisition of ANDX. See Notes 1 and 3.

Summarized balance sheet information for MPLX’s equity method investments as of March 31, 2020 and December 31, 2019 is as follows:
 
March 31, 2020
(In millions)
VIEs
 
Non-VIEs
 
Total
Current assets
$
320

 
$
325

 
$
645

Noncurrent assets
5,384

 
5,115

 
10,499

Current liabilities
153

 
195

 
348

Noncurrent liabilities
$
544

 
$
859

 
$
1,403


 
December 31, 2019
(In millions)
VIEs
 
Non-VIEs
 
Total
Current assets
$
534

 
$
330

 
$
864

Noncurrent assets
5,862

 
5,134

 
10,996

Current liabilities
192

 
245

 
437

Noncurrent liabilities
$
305

 
$
822

 
$
1,127



As of March 31, 2020, the underlying net assets of MPLX’s investees in the G&P segment exceeded the carrying value of its equity method investments by approximately $60 million, after the impairment charges recognized during the quarter. At December 31, 2019, the carrying value of MPLX’s equity method investments in the G&P segment exceeded the underlying net assets of its investees by approximately $1.0 billion. As of March 31, 2020 and December 31, 2019, the carrying value of MPLX’s equity method investments in the L&S segment exceeded the underlying net assets of its investees by $330 million and $329 million, respectively. At March 31, 2020 and December 31, 2019, the G&P basis difference was being amortized into net income over the remaining estimated useful lives of the underlying assets, except for $31 million and $498 million of excess related to goodwill, respectively. At March 31, 2020 and December 31, 2019, the L&S basis difference was being amortized into net income over the remaining estimated useful lives of the underlying assets, except for $167 million of excess related to goodwill, respectively.